2026 Annual Meeting | N2 - Neuroscience in the Clinic: Neurological Care of Individuals with Down Syndrome Across the Lifespan

Date Sunday 04/19/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Chad Hales, MD, PhD, FAAN, Jonathan Santoro, MD

Topic(s) Child Neurology and Developmental Neurology, General Neurology

Learning Objectives Participants should be able to identify the unique aspsects of epilepsy care in individuals with Down syndrome ranging from differences in age of onset, response to anti-seizure medications, and long-term sequelae; understand the core clinical symptoms of Down Syndrome Regression Disorder (DSRD) and formulate therapeutic management plans based on neurodiagnostic study results; and understand the unique causes of Alzheimer's in persons with Down syndrome and understand novel therapeutic strategies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 03:33 PM CDT	Introduction	Introduction Chad Hales, MD, PhD, FAAN, Jonathan Santoro, MD
03:33 PM - 04:03 PM CDT	Speaker	Epilepsy in Down Syndrome Carl E. Stafstrom, MD, PhD
04:03 PM - 04:15 PM CDT	Speaker	Abstract Presentation #1
04:15 PM - 04:45 PM CDT	Speaker	Down Syndrome Regression Disorder and Abstract Presentation #2 Jonathan Santoro, MD
04:45 PM - 04:57 PM CDT	Speaker	Abstract Presentation #3
04:57 PM - 05:27 PM CDT	Speaker	Alzheimer's in Down Syndrome Beau M. Ances, MD, PhD, MS, FAAN
05:27 PM - 05:30 PM CDT	Closing Remarks	Conclusion Chad Hales, MD, PhD, FAAN, Jonathan Santoro, MD

Faculty Disclosures
Carl E. Stafstrom, MD, PhD	Dr. Stafstrom has nothing to disclose.
Beau M. Ances, MD, PhD, MS, FAAN	Dr. Ances has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH.
Chad Hales, MD, PhD, FAAN	The institution of Dr. Hales has received research support from BrightFocus foundation. The institution of Dr. Hales has received research support from NIH. The institution of Dr. Hales has received research support from State of Georgia. Dr. Hales has a non-compensated relationship as a committee member with AAN that is relevant to AAN interests or activities.
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.

��ɫ��

��ɫ��